文献速递糖尿病

SHP-1激活抑制胰岛素抵抗和糖尿病啮齿动物模型中血管平滑肌细胞增殖及内膜增生

SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.
PubMed 文献 · Diabetologia · 2016-12-09

本研究在股动脉导丝损伤小鼠模型、胰岛素抵抗和糖尿病啮齿动物模型及2型糖尿病患者中探讨SHP-1的作用。高脂饮食小鼠股动脉内膜增生增加且动脉SHP-1表达降低,氧化LDL通过激活Mek-1和增加Shp-1启动子DNA甲基化抑制SHP-1表达;在血管平滑肌细胞过表达SHP-1的转基因小鼠及使用SHP-1诱导剂Icariside II处理的小鼠中,导丝损伤后内膜增生受到保护。作者认为增强SHP-1水平是维持胰岛素抵抗和糖尿病患者支架通畅性的潜在治疗策略。

要点

  • 高脂饮食小鼠股动脉内膜增生增加且动脉SHP-1表达降低。
  • 氧化LDL通过激活Mek-1并增加Shp-1启动子DNA甲基化抑制SHP-1表达。
  • Shp-1转基因小鼠及Icariside II处理小鼠在导丝损伤后免于内膜增生。

核心结论

  • 氧化脂质对SHP-1的抑制可能促进糖尿病和胰岛素抵抗动脉中观察到的血管平滑肌细胞过度增殖、炎性细胞因子产生和内膜增生。
  • 增强SHP-1水平是维持胰岛素抵抗和糖尿病患者支架通畅性的潜在治疗策略。

研究设计与样本

  • 研究使用股动脉导丝损伤小鼠模型、胰岛素抵抗和糖尿病啮齿动物模型以及2型糖尿病患者。
  • 通过在血管平滑肌细胞过表达SHP-1的转基因小鼠(Shp-1-Tg)调控SHP-1表达,并使用SHP-1激动剂研究氧化脂质调控SHP-1的分子机制。

主要发现

  • 与常规饮食小鼠相比,高脂饮食小鼠股动脉内膜增生增加且动脉SHP-1表达降低。
  • Zucker fatty大鼠、Zucker diabetic fatty大鼠及2型糖尿病患者动脉SHP-1表达也降低。
  • 在原代培养血管平滑肌细胞中,氧化LDL通过激活Mek-1(亦称Map2k1)抑制SHP-1表达并增加Shp-1启动子DNA甲基化。
  • Shp-1-Tg小鼠血管平滑肌细胞中血小板衍生生长因子(PDGF)刺激的酪氨酸磷酸化受损,同时PDGF刺激的血管平滑肌细胞增殖和迁移减少。
  • 高脂饮食的Shp-1-Tg小鼠及使用SHP-1诱导剂Icariside II处理的小鼠在导丝损伤后免于内膜增生发生。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Accelerated migration and proliferation of vascular smooth muscle cells (VSMCs) enhances arterial restenosis after angioplasty in insulin resistance and diabetes. Elevation of Src homology 2-containing protein tyrosine phosphatase 1 (SHP-1) induces apoptosis in the microvasculature. However, the role of SHP-1 in intimal hyperplasia and restenosis has not been clarified in insulin resistance and diabetes. METHODS: We used a femoral artery wire injury mouse model, rodent models with insulin resistance and diabetes, and patients with type 2 diabetes. Further, we modulated SHP-1 expression using a transgenic mouse that overexpresses SHP-1 in VSMCs (Shp-1-Tg). SHP-1 agonists were also employed to study the molecular mechanisms underlying the regulation of SHP-1 by oxidised lipids. RESULTS: Mice fed a high-fat diet (HFD) exhibited increased femoral artery intimal hyperplasia and decreased arterial SHP-1 expression compared with mice fed a regular diet. Arterial SHP-1 expression was also decreased in Zucker fatty rats, Zucker diabetic fatty rats and in patients with type 2 diabetes. In primary cultured VSMCs, oxidised LDL suppressed SHP-1 expression by activating Mek-1 (also known as Map2k1) and increased DNA methylation of the Shp-1 promoter. VSMCs from Shp-1-Tg mice exhibited impaired platelet-derived growth factor (PDGF)-stimulated tyrosine phosphorylation with a concomitant decrease in PDGF-stimulated VSMC proliferation and migration. Similarly, HFD-fed Shp-1-Tg mice and mice treated with the SHP-1 inducer, Icariside II, were protected from the development of intimal hyperplasia following wire injury. CONCLUSIONS/INTERPRETATION: Suppression of SHP-1 by oxidised lipids may contribute to the excessive VSMC proliferation, inflammatory cytokine production and intimal hyperplasia observed in arteries from diabetes and insulin resistance. Augmenting SHP-1 levels is a potential therapeutic strategy to maintain stent patency in patients with insulin resistance and diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Qi W, Li Q, Liew CW, et al. SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes. Diabetologia. 2016. PMID: 27933336. doi:10.1007/s00125-016-4159-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。